A Phase III, Multicenter, Randomized, Placebo-Controlled Clinical Trial of Topical Aminocaproic Acid (Caprogel) in the Management of Traumatic Hyphema

Ophthalmology

Volumn 110, Issue 11, 2003, Pages 2106-2112

  Pieramici, Dante J ^a,b,l   Goldberg, Morton F ^a   Melia, Michele ^a   Fekrat, Sharon ^a,c   Bradford, Cynthia A ^d   Faulkner, Alan ^e   Juzych, Mark ^f   Parker, John S ^g   McLeod, Stephen D ^h   Rosen, Richard ⁱ   Santander, Samuel H ^j,k  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b California Retina Consultants and Research Foundation   (United States)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NEW YORK EYE AND EAR INFIRMARY   (United States)

^j UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^k Carolina Vision Consultants   (United States)

^l California Retina Consultants   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CATARACT; CHILD; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EYE INJURY; EYE PAIN; EYE TOXICITY; FEMALE; HUMAN; HYPHEMA; INTRAOCULAR HEMORRHAGE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0242349279     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00866-2     Document Type: Article

References (21)

1. Read J, Goldberg MF. Comparison of medical treatment for traumatic hyphema. Trans Am Acad Ophthalmol Otolaryngol 1974;78:799-815.
2. Gottsch JD. Hyphema: diagnosis and management. Retina 1990; 10(suppl 1):S65-71.
3. Crouch ER Jr, Frenkel M. Aminocaproic acid in the treatment of traumatic hyphema. Am J Ophthalmol 1976;81:355-60.
4. Palmer DJ, Goldberg MF, Frenkel M, et al. A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas. Ophthalmology 1986;93:102-8.
5. Crouch ER Jr, Williams PB, Gray MK, et al. Topical aminocaproic acid in the treatment of traumatic hyphema . Arch Ophthalmol 1997;115:1106-12.
6. Aylward GW. Dunlop IS, Little BC. Meta-analysis of systemic anti-fibrinolytics in traumatic hyphaema. Eye 1994;8:440-2.
7. Farber MD, Fiscella R, Goldberg MF. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema: a randomized clinical trial. Ophthalmology 1991;98:279-86.
8. Wilson TW, Jeffers JB, Nelson LB. Aminocaproic acid prophylaxis in traumatic hyphema. Ophthalmic Surg 1990;21:807-9.
9. Kraft SP, Christianson MD, Crawford JS, et al. Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid. Ophthalmology 1987;94:1232-7.
10. Kutner B, Fourmian S, Brein K. et al. Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema. Arch Ophthalmol 1987;105:206-8.
11. McGetrick JJ, Jampol LM, Goldberg MF, et al. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema. Arch Ophthalmol 1983;101:1031-3.
12. Shiuey Y, Lucarelli MJ. Traumatic hyphema outcomes of outpatient management. Ophthalmology 1998; 105:851-5.
13. Spoor TC, Kwitko GM, O'Grady JM, Ramocki JM. Traumatic hyphema in an urban population. Am J Ophthalmol 1990;109:23-7.
14. Teboul BK, Jacob JL, Barsoum-Homsy M, et al. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children. Ophthalmology 1995;102:1646-53.
15. Volpe NJ, Larrison WI, Hersh PS, et al. Secondary hemorrhage in traumatic hyphema. Am J Ophthalmol 1991;112:507-13.
16. Allingham RR, Crouch ER Jr, Williams PB, et al. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the Rabbit Model. Arch Ophthalmol 1988;106:1436-8.
17. Allingham RR, Williams PB, Crouch ER Jr, et al. Topically applied aminocaproic acid in concentrates in the aqueous humor of the rabbit in therapeutic levels. Arch Opthalmol 1987; 105:1421-3.
18. Rahmani B, Jahadi HR, Rajaeefard A. An analysis of risk for secondary hemorrhage in traumatic hyphema. Ophthalmology 1999;106:380-5.
19. Fong LP. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis. Ophthalmology 1994;101:1583-8.
20. Ng CS, Sparrow JM, Strong NP. Rosenthal AR. Factors related to final visual outcome of 425 patients with traumatic hyphema. Eye 1992;6:305-7.
21. Lai JC, Fekrat S, Barron Y, Goldberg MF. Traumatic hyphema in children: risk factors for complications. Arch Ophthalmol 2001;119:64-70.